Active	Status	Sponsor type	Region	Phase	Filter
4 Active 8 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Garg, Satish K
QWINT-5, NCT05463744: A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy	Completed	3	692	Europe, Japan, US, RoW	Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec	Eli Lilly and Company	Type 1 Diabetes, Diabetes	05/24	05/24
OPTI-2, NCT06238778: Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec	Recruiting	2	230	US	HDV-Lispro, HDV-L, Lispro, LIS	Diasome Pharmaceuticlas, Inc.	Diabetes Mellitus, Type 1	06/25	12/25
NCT05714059: Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM	Completed	N/A	250	US	Insulin Pump with Continuous Glucose Monitoring	Medtronic Diabetes	Type 1 Diabetes	12/23	12/23
NCT06719531: SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes	Not yet recruiting	N/A	1500	US	Continuous Glucose Monitoring	Medtronic Diabetes	Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus	12/25	12/25